Skip to main content
Clinical Trials/NCT02629016
NCT02629016CompletedNot Applicable

Stress Reduction: A Pilot Study With Adolescents

Oregon Health and Science University0 sites285 target enrollmentStarted: September 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
285
Primary Endpoint
Depression Anxiety and Stress Scale (DASS)

Study Overview

Brief Summary

This study will evaluate the feasibility of providing an onsite mindfulness intervention, delivered as part of the school health curriculum, to help high school-attending adolescents cope with stress.

Detailed Description

For this study, sophomores who are enrolled in health at Jesuit High School, (n = 320 students) will be invited to participate in a research study, conducted during health class, comparing mindfulness to a wellness or waitlist control. The students will be randomized by classroom, to either wellness or mindfulness or waitlist, with approximately 3-4 classes per intervention or control. Initially, six classes or sections of health will be randomized to one of the two active interventions, with the remaining classes/sections of health on the waitlist. Both of the intervention groups will meet weekly, during one of the regularly scheduled health classes, and have daily assignments. The students in the waitlisted classrooms will receive an intervention at the start of the next term. At the end of the study, students will have access to the materials from the other group, if desired.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
14 Years to 70 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Adolescents who are enrolled in health class at Jesuit High School,
  • Who have access to an iPad, cell phone or computer,
  • Are considered reliable and compliant with the study protocol including willing to abide by randomization process, willingness to commit to daily practice activities for the duration of the study.
  • Students taking psychiatric medication including stimulants, anti-depressants or anxiolytics are eligible to participate provided they are stable on their current dose of medication, have been taking it for at least two weeks, and will remain on the same dose for the remainder of the study. Any changes in medication will be noted.
  • Intellectual disability, as reported by parent or teacher;
  • Current manic episode
  • Psychotic episode
  • Untreated Post Traumatic Stress Disorder, identified through parent or student report.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Depression Anxiety and Stress Scale (DASS)

Time Frame: Change in DASS score from baseline (week 0) to post-intervention (week 9)

Baseline to post-intervention or waitlist DASS change score

Automatic Thoughts Questionnaires (ATQ)

Time Frame: Change score from baseline (week 0) to post-intervention (week 9) on ATQ

Baseline to post-intervention or waitlist ATQ change score

Conners 3 Short Form

Time Frame: Change score from baseline (week 0) to post-intervention (week 9) on Conners

Baseline to post-intervention or waitlist Conners change score

Secondary Outcomes

  • Sleep Quality(Change score from baseline (week 0) to post-intervention (week 9) on sleep)
  • Stress Reactivity(Change score from baseline (week 0) to post-intervention (week 9) in beats per minute)
  • Stress reactivity(Change score from baseline (week 0) to post-intervention (week 9) blood pressure (BP) sys/dia measurement)
  • Self-report stress on behavioral tasks(Change score from baseline (week 0) to post-intervention (week 9) on self-rated stress (0-10 likert scale))
  • Perceived Stress Scale (PSS)(Change score from baseline (week 0) to post-intervention (week 9) on PSS)
  • Five Factor Mindfulness Questionnaire (FFMQ)(Change score from baseline (week 0), post-intervention (week 9) on FFMQ)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jeanette Johnstone

Principal Investigator

Oregon Health and Science University

Similar Trials